About Us
- Home
- About Us
About Sickle Cell Programme
Coordination, Healthcare, Advocacy, Research, and Training in Africa
The Sickle Cell Programme (SCP)
SCP was established with a singular focus to alleviate the global impact of Sickle Cell Disease through comprehensive Coordination, Healthcare, Advocacy, Research, and Training. At the heart of our organization is a vision to support government efforts to reduce the burden of Sickle Cell Disease in Tanzania, ensuring that national health strategies are empowered by specialized expertise and sustainable clinical outcomes.
To achieve this, we are driven by a mission to support Coordination, Healthcare, Advocacy, Research, and Training for Sickle Cell Disease (SCD) by uniting a dedicated collective of academicians, researchers, healthcare providers, and passionate individuals. By fostering these critical partnerships, we work to promote, strengthen, and develop a robust framework that advances the standard of care and scientific inquiry within Tanzania, ultimately transforming the lives of those affected by this condition.
Our Team
Our strength lies in our multidisciplinary team of world-renowned scientists, clinicians, and support staff. Comprising experts in hematology, genetics, molecular biology, public health, data scientists, statistician, ICT and clinical trials, our team brings diverse perspectives and extensive experience to address the multifaceted challenges of SCD. We are committed to upholding the highest standards of scientific rigor and ethical conduct in all our endeavors.
At the Sickle Cell Programme, we believe that collaboration, innovation, and commitment are essential for making a lasting impact. Our diverse team brings a wide range of expertise and insights, helping us design inclusive, effective, and sustainable interventions. United by purpose, we are working toward a healthier future.
Advisory Excellence: The Experts Supporting Our Mission
Meet the esteemed advisors behind the mission who provide the high-level expertise and strategic vision steering our efforts. Each advisor brings decades of unique experience and dedication, offering critical guidance in the fields of healthcare, research, and community advocacy. Learn more about the individuals who illuminate our path and ensure our mission to improve the lives of those affected by sickle cell disease is impactful and sustainable.
Appolinary A. R. Kamuhabwa is a Professor in Pharmacology at Muhimbili University of Health and Allied Sciences;. He did his first degree in Pharmacy at the University of Dar es Salaam and graduated in 1994. Afterward, he pursued a Master’s, PhD, and Postdoctoral fellowship in Pharmacology at the Catholic University of Leuven in Belgium. In 2001 he joined Muhimbili University of Health and Allied Sciences as a Lecturer and attained the rank of Professor in 2016. Concerning research, areas of interest are therapeutics and other pharmacological interventions in infectious and non-infectious diseases. As a Professor in Pharmacology, Prof. Kamuhabwa has carried out a number of research including communicable and non-communicable diseases. He has also conducted a number of researches in Bladder Cancer, HIV, malaria during pregnancy, hypertension, and rheumatic heart disease. He has over twenty-years’ of research experience in Cancer, HIV, Malaria, and cardiovascular diseases. Recently, Prof. Kamuhabwa has been involved in research and advocacy for Sickle Cell Disease in Tanzania. As an advisor for the Sickle Cell Program at Muhimbili University of Health and Allied Sciences, since 2019, he has participated in high-level side meetings during the United Nations General Assembly (UNGA) in New York, US.
Prof. Kamuhabwa has published over 100 papers in peer-reviewed research articles and supervised 16 Masters and 6 PhD students. He has received grants and collaborated with a number of organizations and research institutions including Management Science for Health, USAID, Sida-Sweden, and The European and Developing Countries Clinical Trials Partnership (EDCPT). Locally he has worked with the Ministry of Health in Tanzania for training and capacity building of human resources for health; the Neglected Tropical Disease Control Program, the National AIDS Control Program, Tanzania Medicines and Medical Devices Authority, the National Clinical Trial Committee, and the National Council for Technical Education.
Prof. Kamuhabwa has served as the Director of Planning and Development at Muhimbili University of Health and Allied Sciences from 2007 up to 2015. He also served as the Deputy Vice Chancellor for Planning, Finance, and Administration at Muhimbili University of Health and Allied Sciences from 2015 up to 2017. He has served as Acting Vice Chancellor for Muhimbili University of Health and Allied Sciences from September 2017 up to June 2018 and as the Deputy Vice-Chancellor responsible for Academic, Research and Consultancy (DVC-ARC) at Muhimbili University of Health and Allied Sciences from July 2018 to June 2023. Since June 2023, he has been serving as the Acting Vice Chancellor of Muhimbili University of Health and Allied Sciences.
Prof. Appolinary Kamuhabwa is also a Board Member of the Tanzania Medicines and Medical Devices Authority, Jakaya Kikwete Cardiac Institute, and the Catholic University of Health and Allied Sciences in Tanzania.
Appolinary A. R. Kamuhabwa is a Professor in Pharmacology at Muhimbili University of Health and Allied Sciences;. He did his first degree in Pharmacy at the University of Dar es Salaam and graduated in 1994. Afterward, he pursued a Master’s, PhD, and Postdoctoral fellowship in Pharmacology at the Catholic University of Leuven in Belgium. In 2001 he joined Muhimbili University of Health and Allied Sciences as a Lecturer and attained the rank of Professor in 2016. Concerning research, areas of interest are therapeutics and other pharmacological interventions in infectious and non-infectious diseases. As a Professor in Pharmacology, Prof. Kamuhabwa has carried out a number of research including communicable and non-communicable diseases. He has also conducted a number of researches in Bladder Cancer, HIV, malaria during pregnancy, hypertension, and rheumatic heart disease. He has over twenty-years’ of research experience in Cancer, HIV, Malaria, and cardiovascular diseases. Recently, Prof. Kamuhabwa has been involved in research and advocacy for Sickle Cell Disease in Tanzania. As an advisor for the Sickle Cell Program at Muhimbili University of Health and Allied Sciences, since 2019, he has participated in high-level side meetings during the United Nations General Assembly (UNGA) in New York, US.
Prof. Kamuhabwa has published over 100 papers in peer-reviewed research articles and supervised 16 Masters and 6 PhD students. He has received grants and collaborated with a number of organizations and research institutions including Management Science for Health, USAID, Sida-Sweden, and The European and Developing Countries Clinical Trials Partnership (EDCPT). Locally he has worked with the Ministry of Health in Tanzania for training and capacity building of human resources for health; the Neglected Tropical Disease Control Program, the National AIDS Control Program, Tanzania Medicines and Medical Devices Authority, the National Clinical Trial Committee, and the National Council for Technical Education.
Prof. Kamuhabwa has served as the Director of Planning and Development at Muhimbili University of Health and Allied Sciences from 2007 up to 2015. He also served as the Deputy Vice Chancellor for Planning, Finance, and Administration at Muhimbili University of Health and Allied Sciences from 2015 up to 2017. He has served as Acting Vice Chancellor for Muhimbili University of Health and Allied Sciences from September 2017 up to June 2018 and as the Deputy Vice-Chancellor responsible for Academic, Research and Consultancy (DVC-ARC) at Muhimbili University of Health and Allied Sciences from July 2018 to June 2023. Since June 2023, he has been serving as the Acting Vice Chancellor of Muhimbili University of Health and Allied Sciences.
Prof. Appolinary Kamuhabwa is also a Board Member of the Tanzania Medicines and Medical Devices Authority, Jakaya Kikwete Cardiac Institute, and the Catholic University of Health and Allied Sciences in Tanzania.
Appolinary A. R. Kamuhabwa is a Professor in Pharmacology at Muhimbili University of Health and Allied Sciences;. He did his first degree in Pharmacy at the University of Dar es Salaam and graduated in 1994. Afterward, he pursued a Master’s, PhD, and Postdoctoral fellowship in Pharmacology at the Catholic University of Leuven in Belgium. In 2001 he joined Muhimbili University of Health and Allied Sciences as a Lecturer and attained the rank of Professor in 2016. Concerning research, areas of interest are therapeutics and other pharmacological interventions in infectious and non-infectious diseases. As a Professor in Pharmacology, Prof. Kamuhabwa has carried out a number of research including communicable and non-communicable diseases. He has also conducted a number of researches in Bladder Cancer, HIV, malaria during pregnancy, hypertension, and rheumatic heart disease. He has over twenty-years’ of research experience in Cancer, HIV, Malaria, and cardiovascular diseases. Recently, Prof. Kamuhabwa has been involved in research and advocacy for Sickle Cell Disease in Tanzania. As an advisor for the Sickle Cell Program at Muhimbili University of Health and Allied Sciences, since 2019, he has participated in high-level side meetings during the United Nations General Assembly (UNGA) in New York, US.
Prof. Kamuhabwa has published over 100 papers in peer-reviewed research articles and supervised 16 Masters and 6 PhD students. He has received grants and collaborated with a number of organizations and research institutions including Management Science for Health, USAID, Sida-Sweden, and The European and Developing Countries Clinical Trials Partnership (EDCPT). Locally he has worked with the Ministry of Health in Tanzania for training and capacity building of human resources for health; the Neglected Tropical Disease Control Program, the National AIDS Control Program, Tanzania Medicines and Medical Devices Authority, the National Clinical Trial Committee, and the National Council for Technical Education.
Prof. Kamuhabwa has served as the Director of Planning and Development at Muhimbili University of Health and Allied Sciences from 2007 up to 2015. He also served as the Deputy Vice Chancellor for Planning, Finance, and Administration at Muhimbili University of Health and Allied Sciences from 2015 up to 2017. He has served as Acting Vice Chancellor for Muhimbili University of Health and Allied Sciences from September 2017 up to June 2018 and as the Deputy Vice-Chancellor responsible for Academic, Research and Consultancy (DVC-ARC) at Muhimbili University of Health and Allied Sciences from July 2018 to June 2023. Since June 2023, he has been serving as the Acting Vice Chancellor of Muhimbili University of Health and Allied Sciences.
Prof. Appolinary Kamuhabwa is also a Board Member of the Tanzania Medicines and Medical Devices Authority, Jakaya Kikwete Cardiac Institute, and the Catholic University of Health and Allied Sciences in Tanzania.
